JCP

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Read responses to this article
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Alonso, A
Right arrow Articles by Amorim, A
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Alonso, A
Right arrow Articles by Amorim, A
Journal of Clinical Pathology 2005;58:83-86
© 2005 BMJ Publishing Group Ltd & Association of Clinical Pathologists


SHORT REPORT

Mitochondrial DNA haplotyping revealed the presence of mixed up benign and neoplastic tissue sections from two individuals on the same prostatic biopsy slide

A Alonso1, C Alves2, M P Suárez-Mier3, C Albarrán1, L Pereira2, L Fernández de Simón1, P Martín1, O García4, L Gusmão2, M Sancho1, A Amorim2

1 Instituto Nacional de Toxicología y Ciencias Forenses, Servicio de Biología, Luis Cabrera 9, 28002 Madrid, Spain
2 Instituto de Patologia e Imunologia Molecular da Universidade do Porto (IPATIMUP), Rua Dr Roberto Frias, s/n 4200-465 Porto, Portugal
3 Instituto Nacional de Toxicología y Ciencias Forenses, Servicio de Histopatologia, Madrid, Spain
4 Area de Laboratorio Ertzaintza, Larrauri Mendotxe Bidea 18, 48950, Erandio, Bizkaia, Spain

Correspondence to:
Dr A Alonso
Instituto Nacional de Toxicología y Ciencias Forenses, Servicio de Biología, Luis Cabrera 9, 28002 Madrid, Spain; a.alonso{at}mju.es
ABSTRACT
DNA typing was requested to investigate a presumptive cancer diagnosis error by confirming whether benign and cancerous prostatic tissue in the same presurgical haematoxylin and eosin stained slide belonged to the same person. After independent histological re-examination of the slide by a pathologist, manual slide dissection was used to guarantee independent and high recovery DNA isolation from each tissue section, avoiding carryover and background contamination. Nuclear DNA quantification performed by real time polymerase chain reaction (PCR) revealed the absence of human DNA for short tandem repeat (STR) typing. Mitochondrial DNA was only obtained by performing PCR of very short fragments (~100 bp), indicating high DNA degradation. Different low frequency hypervariable region I haplotypes were obtained from each tissue section (normal tissue section haplotype: 16224C, 16234T, 16311C, 16356C; cancer tissue section haplotype: 16256T, 16270T, 16293G). Only the normal tissue section haplotype matched that obtained from the patient’s blood sample, indicating that the cancer tissue section originated from an unknown patient. These results supported the hypothesis of sample mix up during block processing or slide preparation by a carryover mechanism. Mitochondrial genetic typing is recommended to exclude the possibility of carryover artefacts when low DNA content and high degradation compromise conventional STR typing.


Abbreviations: AMG, Amelogenin gene; HVI, hypervariable region I; LCN, low copy number; mtDNA, mitochondrial DNA; PCR, polymerase chain reaction; STR, short tandem repeat; TS, tissue section




eLetters:

Read all eLetters

MtDNA haplotyping of pathology specimens
Ryan L. Parr, et al.
JCP Online, 8 Feb 2005 [Full text]
Author's reply to Parr et al.
Antonio Alonso
JCP Online, 15 Feb 2005 [Full text]



HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Journal of Clinical Pathology Molecular Pathology
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2005 by the BMJ Publishing Group Ltd & Association of Clinical Pathologists.